IFI-K · Lanthionine Peptide

Specimen SS-F-KOK-567 // KOKUMI · IFI-K

Lanthionine Peptide I-IV-A

Saccharomyces cerevisiae

Yeast

Tier ILanthionine Peptide

Target Trait

1.4×

fold-change

Cyclic lanthipeptide-analog CaSR ligand fold-change in Saccharomyces cerevisiae

Technical Specifications

SKU

SS-F-KOK-567

Genomic Edits

4

GC Content

44.7%

Construct Length

2,790 bp

Promoter System

T7/SP6 cell-free

Expression System

Cell-free in vitro transcription/translation

Host Strain

T7 RNA Polymerase

Receptor Target

CaSR (calcium-sensing receptor)

IFI Score

140

Pathway Edits

  • LANM (lanthipeptide modifying enzyme homolog) activity-tuned expression for Lan dehydration
  • LANB (lanthipeptide biosynthesis protein B) protease expression for leader peptide cleavage
  • LanC-like cyclase expression for lanthionine ring structure formation in yeast
  • ProcA precursor peptide cassette expression with optimized leader sequence
  • Lanthipeptide ABC transporter expression for extracellular cyclic peptide secretion
  • Lan-RG (lanthipeptide regulator/immunity protein) expression for pathway stability
  • Prepeptide processing protease expression for mature cyclic CaSR ligand liberation

Key Interventions

LANM/LANB lanthipeptide modification and cleavage pathway for cyclic CaSR peptide scaffold productionLanC-like cyclase expression for lanthionine ring formation creating conformationally constrained CaSR ligandProcA precursor and ABC transporter for extracellular accumulation of mature cyclic kokumi compoundCell-free in vitro transcription/translation delivery optimized for Saccharomyces cerevisiae genome accessibilityTier-I construct validated with 4 precision edits for 1.4× fold-change

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
140
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Research-grade cyclic peptide CaSR ligand for lanthipeptide kokumi mechanism studies

License

$299 · Tier I License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Kokumi · IFI-KAll Modalities